Chinese drug regulator China Food and Drug Administration (CFDA) on 15 January 2015 approved a new vaccine S-IPV to treat the Poliomyelitis.
The vaccine S-IPV is known as Ai Bi Wei in China. It is manufactured by the Institute of Medical Biology of the Chinese Academy of Medical Sciences located in Kunming, southwest China's Yunnan province.
The vaccine will be given to Chinese children as part of routine disease prevention and will help the global fight against the polio virus. The World Health Organisation is also considering use of this new vaccine in its global polio treatment program.
Poliomyelitis is a highly contagious disease caused by the poliovirus, which attacks the nervous system and can cause lifelong paralysis or even death.
China technically eradicated polio in 2000, but there have been outbreaks of the disease in the country since then. In this case, the S-IPV is a breakthrough for China to keep the polio-free status.
When: 15 January 2015
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.